Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.50
Delayed Data
As of Jan 23
 +0.40 / +2.65%
Today’s Change
11.90
Today|||52-Week Range
18.99
+1.97%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale1/02/2018170,225$15.30$2.6M-0.64%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Buy1/02/2018250,000$5.76$1.4M-0.64%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale1/02/201821,535$15.30$329.5K-0.64%
Gulino Richard L
General Counsel & Senior Vice President
Sale1/02/201810,367$15.20$157.6K-0.64%
Kelly James Patrick /vanda/
Chief Financial Officer & Executive Vice President
Sale1/02/20189,155$15.35$140.5K-0.64%
Birznieks Gunther
Senior Vice President-Business Development
Sale1/02/20188,568$15.26$130.7K-0.64%
Bate Kenneth M
Director
Gift6/15/20175,000$0.00$0.00+12.73%
Gulino Richard L
General Counsel & Senior Vice President
Gift3/01/201730,000$0.00$0.00+6.90%
Kelly James Patrick /vanda/
Chief Financial Officer & Executive Vice President
Gift3/01/201770,000$0.00$0.00+6.90%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Gift3/01/2017200,000$0.00$0.00+6.90%
Page of 3